1. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth
   Neha Singh et al, 2020, Molecular Oncology CrossRef
2. Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer
   Anushka Sharma et al, 2024, Molecular Diversity CrossRef
3. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β
   Rui-Fang Fan et al, 2017, Molecular Medicine Reports CrossRef
4. Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation
   Mona H. Ibrahim et al, 2022, Bioorganic Chemistry CrossRef
5. PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells
   Carolin Seifert et al, 2021, International Journal of Molecular Sciences CrossRef
6. Synthesis of new pyridothienopyrimidinone and pyridothienotriazolopyrimidine derivatives as pim-1 inhibitors
   Hala B. El-Nassan et al, 2018, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
7. Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors
   Bassem H. Naguib et al, 2017, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
8. Structure-Based Optimization of 10-DEBC Derivatives as Potent and Selective Pim-1 Kinase Inhibitors
   Gudong Li et al, 2020, Journal of Chemical Information and Modeling CrossRef
9. The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics
   Zhao Deng et al, 2023, Pharmacological Reviews CrossRef
10. Application and SARs of Pyrazolo[1,5-a]pyrimidine as Antitumor Agents Scaffold
    Yadong Zhang et al, 2023, Current Topics in Medicinal Chemistry CrossRef
11. miR24‐2 accelerates progression of liver cancer cells by activating Pim1 through tri‐methylation of Histone H3 on the ninth lysine
    Yuxin Yang et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
12. New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study
    Amel M. Farrag et al, 2020, Bioorganic Chemistry CrossRef
13. Therapeutic targeting of PIM KINASE signaling in cancer therapy: Structural and clinical prospects
    Aanchal Rathi et al, 2021, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
14. Pim-1 kinase as cancer drug target: An update
    YERNAR TURSYNBAY et al, 2016, Biomedical Reports CrossRef
15. Breast Cancer Resistance Protein: A Potential Therapeutic Target for Cancer
    Sonali Mehendale-Munj et al, 2021, Current Drug Targets CrossRef
16. Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
    Manuel-Pedro Jiménez-García et al, 2017, Oncotarget CrossRef
17. PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
    Sabina Luszczak et al, 2020, Signal Transduction and Targeted Therapy CrossRef
18. Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors
    Bruno Oyallon et al, 2018, European Journal of Medicinal Chemistry CrossRef
19. The Role of PIM Kinases in Pediatric Solid Tumors
    Janet Rae Julson et al, 2022, Cancers CrossRef
20. Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
    Anantha N. Nagappa et al, 2020, Current Enzyme Inhibition CrossRef
21. The role of PIM1/PIM2 kinases in tumors of the male reproductive system
    Manuel Pedro Jiménez-García et al, 2016, Scientific Reports CrossRef
22. Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214
    Po-Shuan Huang et al, 2017, Scientific Reports CrossRef